Study of CSTI-500 for people with Prader-Willi syndrome
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests an investigational drug called CSTI-500 for people with Prader-Willi syndrome who are in the hyperphagia (constant hunger) phase. It aims to see if the drug can improve behavior and reduce overeating. You and your caregiver will need to visit the clinic regularly and answer questions about symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 13 to 50 years old and generally healthy.
- Must have a confirmed genetic diagnosis of Prader-Willi syndrome (not the UPD type) and be in the hyperphagia phase (Nutritional Phase 3).
- Must have at least a moderate level of behavioral symptoms (CGI-S score 4 or higher) and hyperphagia (HQ-CT total score 13 or higher).
- Must stop taking most psychiatric medications (like antidepressants, stimulants, or antipsychotics) at least 30 days before starting and not take them during the study.
- Must have a caregiver who can come to visits, stay with you, and answer questions.
- Women who can get pregnant must use birth control during the study and for 30 days after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called BMB-101 to see if it can help control extreme hunger in adults with Prader-Willi Syndrome. It aims to improve safety and quality of life.
This trial studies whether taking prebiotics and probiotics can help children with Prader-Willi syndrome manage obesity. It’s testing a gut-focused approach to weight control over the study period.
This study tests an oral medication, pitolisant, in people with Prader-Willi syndrome who have already been in a pitolisant study. It aims to see if continuing treatment is safe and effective.
This trial tests a medication called pitolisant to see if it helps reduce excessive daytime sleepiness in people with Prader-Willi syndrome. You or your loved one may be able to join if they have a confirmed diagnosis and a caregiver who can regularly help with study tasks.
This trial studies whether targeted brain stimulation (TMS) can help with appetite and eating feelings in people with Prader-Willi syndrome. It also includes an MRI scan to measure brain-related effects, but only if you can safely have these scans.
This study tests a group therapy program designed to help teenagers with Prader-Willi syndrome (a genetic condition) learn better emotional control and regulation skills. Your teen and family would attend weekly group sessions to practice tools for managing emotions like anger or frustration.
Hear when a new Prader-Willi Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.